Citadel Advisors’s Guardian Pharmacy Services GRDN Stock Holding History

Citadel Advisors’s Portfolio GRDN Stock Details GRDN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$21.8M	Buy	+579,121	New	+$18.9M	﹤0.01%	2232
2025 Q4	–	Sell	-77,663	Closed	-$2.04M	–	14435
2025 Q3	$2.04M	Sell	77,663 -241,585	-76%	-$5.76M	﹤0.01%	6029
2025 Q2	$6.8M	Buy	+319,248	New	+$7.2M	﹤0.01%	3596
2024 Q4	–	Sell	-401,131	Closed	-$6.74M	–	15593
2024 Q3	$6.74M	Buy	+401,131	New	+$6.76M	﹤0.01%	3477

Other funds holding GRDN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

VCM

Valiant Capital Management San Francisco, California $1.74B AUM 64.05% 1-Year Est. Return

TCM

TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

Citadel Advisors's GRDN Position: Q1 2026 in Review

Citadel Advisors opened a new position in Guardian Pharmacy Services (GRDN) in Q1 2026: 579,121 shares worth $21.8M. The stake represents ﹤0.01% of the portfolio and ranks #2232 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in GRDN as recently as Q3 2025.

Citadel Advisors first reported a position in GRDN in Q3 2024 and has held it in 4 quarters since. 171 funds tracked by Wall St. Rank hold GRDN as of Q1 2026.

Citadel Advisors held 579,121 shares of Guardian Pharmacy Services worth $21.8M as of Q1 2026.
Guardian Pharmacy Services was a new Citadel Advisors position in Q1 2026.
Guardian Pharmacy Services made up ﹤0.01% of Citadel Advisors's portfolio in Q1 2026, its #2232 holding.
Citadel Advisors first reported a position in Guardian Pharmacy Services in Q3 2024 and has held it in 4 quarters since.
171 funds tracked by Wall St. Rank held Guardian Pharmacy Services as of Q1 2026.

Based on Citadel Advisors's 13F filing for Q1 2026, filed 15 May 2026.